EquityFlow
›
Companies
› Molab.ai
Molab.ai
Biotech
· Munich, DE
Munich software for molecule development in drug discovery
Funding history
Date
Round
Amount
May 2022
Seed
Molab.ai, a Munich molecule-development biotech-software startup, raised a low seven-figure round from Picus Capital.
—
Investors
Picus Capital
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →